The Week in Review: May 25, 2018 – June 1, 2018
US HCV Guidelines updated with recommendations for pregnant women, prisoners and MSM, DAAs and liver cancer, durability of HBV vaccine, CRV431 (cyclophilin inhibitors) and liver cancer, HCV and gut dysbiosis…..
The Week in Review: May 18, 2018 – May 25, 2018
Liver stiffness measurement as effective community screening tool, hepatitis C infections resulting from medical treatment occur despite clear guidelines, Study Finds Three Major Factors for Liver Cancer…..
The Week in Review: May 11, 2018 – May 18, 2018
Promoting Drug Pricing Policy Resources for Patient Groups, Needle exchanges coming to 2 Canadian prisons, Do fatigue and quality of life improve after hepatitis C is cured?, As HCV Rises Among Pregnant Women, At-Risk Infants Inadequately Screened?, What it’s like to grow up with a disease that’s kept secret…..
The Week in Review: April 28, 2018 – May 11, 2018
CADTH recommends that tenofovir alafenamide (TAF) be reimbursed for the treatment of chronic hepatitis B, Evidence of Hepatitis B has been found in human DNA dating back to the Bronze Age, Biologic Psoriasis Therapies Pose Limited Risk for Hepatitis B Reactivation, Another Drug Diversion Outbreak in Washington State…..